SRRK
Scholar Rock is a Cambridge, Massachusetts-based biopharmaceutical company focused on discovering, developing, and delivering therapies that address diseases rooted in protein growth factors. The company uses a science-first approach to selectively target growth factor biology to treat serious conditions, with a pipeline spanning neuromuscular, cardiometabolic, immuno-oncology, fibrotic, and hematology indications. Scholar Rock emphasizes translating bold science into therapies that improve patients’ lives and offers information for patients, healthcare professionals, and investors through its newsroom and resources.
No recent news for this company.